(Q56992635)

4

0 references

author name string

Felipe A. Oyarzun-Ampuero

1

0 references

Maria I. Loza

3

0 references

Dolores Torres

Macromolecular Bioscience

5

0 references

publication date

23 November 2011

0 references

published in

0 references

volume

12

0 references

issue

2

0 references

page(s)

176-183

0 references

cites work

Inhalative nanomedicine--opportunities and challenges.

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Micro- and nanocarrier-mediated lung targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Nanomedicine in pulmonary delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Pulmonary DNA vaccination: concepts, possibilities and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Inhaled drug therapy for treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Nanoparticles as carriers for nasal vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

A miniaturized nebulization catheter for improved gene delivery to the mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Nanoparticles for nasal vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Transmucosal macromolecular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin: comparison with a low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Ouabain-induced enhancement of rat mast cells response. Modulation by protein phosphorylation and intracellular pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Advances in immunopharmacology of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Alternate treatments in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Nanoparticles as protein and gene carriers to mucosal surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102

Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100102